
Sarepta Therapeutics SRPT
$ 20.78
2.36%
Annual report 2025
added 03-02-2026
Sarepta Therapeutics P/S Ratio 2011-2026 | SRPT
Annual P/S Ratio Sarepta Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.71 | 15.4 | 10.3 | 11.4 | 8.87 | 12.6 | 22.8 | 28.6 | 24.6 | 260 | 401 | 49.2 | 59.5 | 17.2 | 2.48 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 401 | 2.48 | 61.9 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 21.66 | 1.14 % | $ 1.01 B | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.9 | -0.2 % | $ 6.62 M | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
3.33 | $ 22.33 | 1.66 % | $ 3.7 B | ||
|
Esperion Therapeutics
ESPR
|
1.39 | $ 1.94 | 1.31 % | $ 403 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Heron Therapeutics
HRTX
|
1.28 | $ 1.18 | -0.84 % | $ 197 M | ||
|
ImmuCell Corporation
ICCC
|
2.1 | $ 8.26 | -1.07 % | $ 74.6 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Innate Pharma S.A.
IPHA
|
14.7 | $ 1.39 | 0.72 % | $ 235 M | ||
|
Inventiva S.A.
IVA
|
128 | $ 5.11 | -0.78 % | $ 138 M | ||
|
Jaguar Health
JAGX
|
0.0831 | $ 0.29 | -25.25 % | $ 676 K | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M | ||
|
KalVista Pharmaceuticals
KALV
|
17 | $ 19.09 | -2.75 % | $ 1.03 B | ||
|
BioNTech SE
BNTX
|
35.7 | $ 102.36 | -2.94 % | $ 27.2 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
10.5 | $ 4.11 | 0.61 % | $ 439 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 23.18 | -0.34 % | $ 2.95 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.43 | -0.7 % | $ 381 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | - | - | $ 96.9 B | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
13.3 | $ 240.72 | 4.09 % | $ 4.4 B | ||
|
Eli Lilly and Company
LLY
|
14.4 | $ 874.81 | -1.06 % | $ 785 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 2.9 | -0.34 % | $ 4.77 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M |